Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018303
Filing Date
2023-05-05
Accepted
2023-05-05 16:05:21
Documents
52
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prds-20230331.htm   iXBRL 10-Q 1488667
2 EX-31.1 prds-ex31_1.htm EX-31 21129
3 EX-31.2 prds-ex31_2.htm EX-31 21457
4 EX-32 prds-ex32.htm EX-32 21674
  Complete submission text file 0000950170-23-018303.txt   5730811

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prds-20230331_pre.xml EX-101.PRE 300650
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prds-20230331_cal.xml EX-101.CAL 27974
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prds-20230331_lab.xml EX-101.LAB 403716
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prds-20230331_def.xml EX-101.DEF 178883
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prds-20230331.xsd EX-101.SCH 52159
46 EXTRACTED XBRL INSTANCE DOCUMENT prds-20230331_htm.xml XML 952533
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

EIN.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40067 | Film No.: 23893742
SIC: 2834 Pharmaceutical Preparations